Multi-target antidiabetic therapy with voglibose, ubiquinone, and tempol: synergistic effects on liver and skeletal muscle in experimental type 2 diabetes

Abstract Background Type 2 Diabetes Mellitus (T2DM) is a progressive metabolic disorder marked by insulin resistance and chronic hyperglycemia. Although voglibose, an alpha-glucosidase inhibitor, is used in T2DM management, its efficacy is limited, particularly when used alone. This study aimed to i...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Öznur Tufan Akarslan, Dudu Erkoç Kaya, Muhammed Bahaeddin Dörtbudak, Büşra Kilinç, İbrahim Büyüktaşkapulu, Fatma Göktürk, Muhammed Demircioğlu, Ayşe Er, Burak Dik
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	BMC 2025-12-01
Цуврал:	BMC Pharmacology and Toxicology
Нөхцлүүд:	Voglibose Ubiquinone Tempol Insulin resistance
Онлайн хандалт:	https://doi.org/10.1186/s40360-025-01071-2
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!